Medicine
Tenofovir disoproxil 300 mg tablet
Tenofovir disoproxil 300 mg tablet is a generic prescription medicine for oral use, made by 15 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store tenofovir disoproxil fumarate tablets at 25°C (77°F), excursions…
Key facts
- Active ingredient (INN)
- Tenofovir disoproxil
- Brand
- Sold under the generic name
- Strength
- 300 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 30 tablets, 100 tablets, 500 tablets and 22 more
- Manufacturers
- Camber PharmaceuticalsIndiaCiplaIndiaAurobindo PharmaIndiaMacleods PharmaceuticalsIndiaStrides PharmaIndiaBryant Ranch PrepackA-S Medication SolutionsAvKAREAvPAKChartwell RX
- Origin register
- US FDA, United States
- Storage
- Store tenofovir disoproxil fumarate tablets at 25°C (77°F), excursions permitted to 15-30°C(59-86°F). • Keep container tightly closed. • Dispense only in original container. • Do not use if seal over bottle opening is broken or missing.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J05AF07 Tenofovir disoproxil
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 26 January 2018
- Identifiers
- RxCUI 349251, 1243227, 1243324 +1DailyMed set ID 67e0e1b7-6a45-4d63-b569-00826832c25a, 0c7d72d6-bf80-49e0-921c-20169e87e62f, 1ac4c628-f01f-42d4-b8e6-d12273aefc6d +15NDC 50090-7202, 71921-105, 31722-535 +15Application ANDA090636, ANDA209498, ANDA203232 +4
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 30 tablet, film coated in 1 bottle | 65862-421-30 | Aurobindo PharmaIndia | 26 January 2018 |
| 100 tablet, film coated in 1 bottle | 31722-535-01 | Camber PharmaceuticalsIndia | 26 January 2018 |
| 500 tablet, film coated in 1 bottle | 31722-535-05 | Camber PharmaceuticalsIndia | 26 January 2018 |
| 1000 tablet, film coated in 1 bottle | 31722-535-10 | Camber PharmaceuticalsIndia | 26 January 2018 |
| 30 tablet, film coated in 1 bottle | 31722-535-30 | Camber PharmaceuticalsIndia | 26 January 2018 |
| 60 tablet, film coated in 1 bottle | 31722-535-60 | Camber PharmaceuticalsIndia | 26 January 2018 |
| 30 tablet in 1 bottle | 69097-533-02 | CiplaIndia | 26 January 2018 |
| 1000 tablet in 1 bottle | 69097-533-15 | CiplaIndia | 26 January 2018 |
| 30 tablet, film coated in 1 bottle | 33342-096-07 | Macleods PharmaceuticalsIndia | 26 January 2018 |
| 30 tablet in 1 bottle | 64380-714-04 | Strides PharmaIndia | 26 January 2018 |
| 30 tablet, film coated in 1 bottle | 62135-466-30 | Chartwell RX | 30 June 2022 |
| 30 tablet, coated in 1 bottle, plastic | 71921-105-33 | Florida Pharmaceutical Products | 26 November 2025 |
| 30 tablet, coated in 1 bottle, plastic | 69076-105-03 | Quinn Pharmaceuticals | 1 January 2020 |
| 30 tablet, film coated in 1 bottle | 63629-9729-1 | Bryant Ranch Prepack | 11 August 2023 |
| 30 tablet, coated in 1 bottle, plastic | 71335-2364-1 | Bryant Ranch Prepack | 30 April 2024 |
| 15 tablet, coated in 1 bottle, plastic | 71335-2364-2 | Bryant Ranch Prepack | 30 April 2024 |
| 30 tablet, coated in 1 bottle, plastic | 71335-3155-1 | Bryant Ranch Prepack | 13 July 2026 |
| 15 tablet, coated in 1 bottle, plastic | 71335-3155-2 | Bryant Ranch Prepack | 13 July 2026 |
| 30 tablet, film coated in 1 bottle | 50090-7202-0 | A-S Medication Solutions | 1 August 2024 |
| 30 tablet, coated in 1 bottle, plastic | 50090-8173-0 | A-S Medication Solutions | 28 October 2026 |
| 30 tablet, film coated in 1 bottle | 42291-800-30 | AvKARE | 10 January 2019 |
| 20 blister pack in 1 box / 1 tablet in 1 blister pack | 50268-758-12 | AvPAK | 30 March 2020 |
| 30 blister pack in 1 carton / 1 tablet, film coated in 1 blister pack | 0904-6821-04 | Major Pharmaceuticals | 26 January 2018 |
| 30 tablet, film coated in 1 bottle | 16714-820-01 | NorthStar RxLLC | 12 November 2018 |
| 7 tablet, film coated in 1 bottle, plastic | 72789-361-07 | PD-Rx Pharmaceuticals | 26 October 2023 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Tenofovir disoproxil 300 mg tablet.
Other strengths and forms of Tenofovir disoproxil
Clinical summary
Tenofovir disoproxil is a hepatitis B virus nucleoside analog reverse transcriptase inhibitor indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults, among other approved uses. MedsAcross supplies Tenofovir disoproxil for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Tenofovir disoproxilFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Viread prescribing information (Gilead Sciences) · U.S. National Library of Medicine, DailyMed
- Viread: European public assessment report (EPAR) · European Medicines Agency
- Tenofovir disoproxil Viatris (previously Tenofovir disoproxil Mylan): European public assessment report (EPAR) · European Medicines Agency
Need Tenofovir disoproxil 300 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.